severe nasal

Generic: oxymetazoline hydrochloride 0.05%

Labeler: alaina healthcare private limited
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name severe nasal
Generic Name oxymetazoline hydrochloride 0.05%
Labeler alaina healthcare private limited
Dosage Form SPRAY
Routes
NASAL
Active Ingredients

oxymetazoline hydrochloride .05 g/100mL

Manufacturer
ALAINA HEALTHCARE PRIVATE LIMITED

Identifiers & Regulatory

Product NDC 73492-715
Product ID 73492-715_45841b24-2f6e-0147-e063-6394a90aa9fa
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2023-09-15

Pharmacologic Class

Classes
imidazolines [cs] increased sympathetic activity [pe] vasoconstriction [pe] vasoconstrictor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73492715
Hyphenated Format 73492-715

Supplemental Identifiers

RxCUI
1000990
UNII
K89MJ0S5VY

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name severe nasal (source: ndc)
Generic Name oxymetazoline hydrochloride 0.05% (source: ndc)
Application Number M012 (source: ndc)
Routes
NASAL
source: ndc

Resolved Composition

Strengths
  • .05 g/100mL
source: ndc
Packaging
  • 1 BOTTLE, SPRAY in 1 CARTON (73492-715-15) / 15 mL in 1 BOTTLE, SPRAY
source: ndc

Packages (1)

Ingredients (1)

oxymetazoline hydrochloride (.05 g/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "45841b24-2f6e-0147-e063-6394a90aa9fa", "openfda": {"unii": ["K89MJ0S5VY"], "rxcui": ["1000990"], "spl_set_id": ["27747a10-8d1d-41c2-80b9-45452f3b9abc"], "manufacturer_name": ["ALAINA HEALTHCARE PRIVATE LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (73492-715-15)  / 15 mL in 1 BOTTLE, SPRAY", "package_ndc": "73492-715-15", "marketing_start_date": "20230915"}], "brand_name": "Severe Nasal", "product_id": "73492-715_45841b24-2f6e-0147-e063-6394a90aa9fa", "dosage_form": "SPRAY", "pharm_class": ["Imidazolines [CS]", "Increased Sympathetic Activity [PE]", "Vasoconstriction [PE]", "Vasoconstrictor [EPC]"], "product_ndc": "73492-715", "generic_name": "oxymetazoline hydrochloride 0.05%", "labeler_name": "ALAINA HEALTHCARE PRIVATE LIMITED", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Severe Nasal", "active_ingredients": [{"name": "OXYMETAZOLINE HYDROCHLORIDE", "strength": ".05 g/100mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230915", "listing_expiration_date": "20261231"}